In summary, miR130b enhanced B-lymphoma cell sensitivity to OX40 agonistic antibody and LNPs miR130b antagomir through modulating OX40/OX40L-mediated lymphoma cell interaction with Th17 cells via IFNAR1/p-STAT1 axis (Fig. 6k). The gene discussed is TNFRSF4; the disease is lymphoma.